ClinicalTrials.Veeva

Menu

Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function (RF-SPEED)

University of Michigan logo

University of Michigan

Status and phase

Completed
Phase 2
Phase 1

Conditions

Heart Failure, Diastolic

Treatments

Device: Diastolic function assessment
Device: Echocardiography machine GE Vivid E9
Device: Echocardiography system Ultra DCI Model 5000

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT01182805
5R44HL071379 (U.S. NIH Grant/Contract)
RF-SPEED

Details and patient eligibility

About

The purpose of this study is to evaluate a novel ultrasound system's ability to assess the relaxing properties of the heart compared to current techniques.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled to undergo a clinically indicated left heart cardiac catheterization will be recruited for the study.

Exclusion criteria

  • Suspected acute ST elevation myocardial infarction.
  • Acute coronary syndrome with active ongoing chest pain
  • Known or suspected acute aortic dissection
  • Known or suspected cardiac tamponade
  • Known history of unoperated constrictive pericarditis
  • Known or suspected severe aortic stenosis or severe mitral regurgitation
  • Heart rhythm other than sinus rhythm on pre-cath EKG
  • Age < 18 years old
  • Unable to provide informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Single arm study.
Other group
Treatment:
Device: Diastolic function assessment
Device: Echocardiography machine GE Vivid E9
Device: Echocardiography system Ultra DCI Model 5000

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems